Dr. Chachoua is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
New York, NY 10016Phone+1 212-731-5165Fax+1 212-263-8460
Education & Training
- Monash University Faculty of MedicineClass of 1979
Certifications & Licensure
- NY State Medical License 1989 - 2025
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
- New York Magazine: Top Doctors Castle Connolly, 2007-2009, 2012-2014
- Join now to see all
Clinical Trials
- Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma Start of enrollment: 1998 Sep 01
- R115777 in Treating Patients With Relapsed Small Cell Lung Cancer Start of enrollment: 1999 Sep 01
- Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 1997 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 588 citationsRadiotherapy induces responses of lung cancer to CTLA-4 blockadeSilvia C. Formenti, Nils Rudqvist, Encouse B. Golden, Benjamin T. Cooper, Erik Wennerberg
Nature Medicine. 2018-11-05 - 472 citationsLocal radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle ...Encouse B. Golden, Arpit M. Chhabra, Abraham Chachoua, Sylvia Adams, Martin Donach
The Lancet. Oncology. 2015-07-01 - 85 citationsRICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 InhibitorsHaiying Cheng, Yiyu Zou, Jeffrey S. Ross, Kai Wang, Xuewen Liu
Cancer Discovery. 2015-09-14
Journal Articles
- Radiotherapy Induces Responses of Lung Cancer to CTLA-4 BlockadeAbraham Chachoua, Silvia C Formenti, Benjamin Cooper, Kent Friedman, Sandra Demaria, Nature
Press Mentions
- Franco Muggia, a Drug Developer and Former Director of NYU Langone’s Perlmutter Cancer Center, Died Unexpectedly on Sept. 8September 17th, 2021
- NYU Langone Brings Top Talent to Advance Cancer Care in BrooklynMarch 11th, 2021
- Around Brooklyn: BP Adams Joins Anti-Diabetes EffortNovember 17th, 2020
- Join now to see all
Grant Support
- Su101 In Patients W/ Psa+ Prostate Cancer(101 008)National Center For Research Resources1999–2002
- Cisplatin Analog In Malignant Pleural MesotheliomaNational Center For Research Resources2000
- IL-1 Combined With High Dose Cisplatinum For Metastatic MelanomaNational Center For Research Resources1995–1996
- Evaluations Of Cytokine And Chemotherapy CombinationsNational Cancer Institute1992–1994
- Recombinant Human Interleukin-1 In Refractory Carcinoma PatientsNational Center For Research Resources1993
- Gmcsf And Murine Monoclonal Antibody R24 For Metastatic MelanomaNational Center For Research Resources1992–1993
- Recombinant Human Interleukin 1 In Refractory Carcinoma PatientsNational Center For Research Resources1991–1992
- Phase II Trial Of Bropirimine In Aids/KsNational Center For Research Resources1988
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: